최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International journal of antimicrobial agents, v.16 no.3, 2000년, pp.317 - 321
Andriole, Vincent T (Tel.: +1-203-7854141)
AbstractInvasive fungal infections will continue to cause major complications in immunocompromized patients. At the moment, the expansion of antifungal drug research has occurred because there is a critical need for new antifungal agents to treat these life-threatening invasive fungal infections. Th...
Andriole 18 19 1998 Current and future therapy of invasive fungal infections
10.1128/AAC.40.2.279 Georgopapadakou NH, Walsh TJ. Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob. Agents Chemother. 1996; 279-91.
Andriole 1994 Pocket Guide to Systemic Antifungal Therapy
J. Antimicrob. Chemother. Andriole 44 151 1999 10.1093/jac/44.2.151 Current and future antifungal therapy: new targets for antifungal agents
Adv. Pharmacol. Groll 44 343 1998 10.1016/S1054-3589(08)60129-5 Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development
Antimicrob. Agents Chemother. George 40 86 1996 10.1128/AAC.40.1.86 Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis
Schock K, Marino S, Baumgartner T, Andriole VT. Efficacy of a new triazole, BMS-207147, in a model of invasive aspergillosis in immunosuppressed, neutropenic rabbits. In: Programs and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. 1998. Abstract J54, American Society for Microbiology, Washington, D.C., 1998.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.